Redefining Medicine

Redefining Medicine with special guest Stephanie Venn Watson, DVM

Mar 4, 2025

Stephanie Venn Watson, DVM, Co-Founder and CEO of Seraphina Therapeutics, brings her expertise in essential fatty acids to the discussion. She shares fascinating insights about C15:0, a groundbreaking fatty acid discovered during dolphin studies that may hold the key to healthy aging. The conversation delves into cellular fragility syndrome, how C15 helps maintain cellular stability, and its potential benefits for liver health and longevity. With over 60 patents, Stephanie demonstrates how innovative health science can reshape our understanding of nutrition.

11:21

Creator website

Episode guests

Stephanie Venn-Watson

AI Summary

AI Chapters

Episode notes

Podcast summary created with Snipd AI

Quick takeaways

Dr. Stephanie Venn-Watson emphasizes the revolutionary role of C15 as a crucial essential fatty acid linked to healthy aging.

The podcast highlights the significant health benefits of C15 supplementation, including improved liver function and reductions in LDL cholesterol.

Deep dives

The Connection Between Dolphins and Human Health

The podcast discusses groundbreaking research on C15, an essential fatty acid, which was initially discovered through studies of dolphins. These marine mammals, being similar to humans in their biological mechanisms, exhibit signs of aging such as high cholesterol. The unique connection comes from findings that dolphins require C15 for healthy aging, just as humans do. Researchers have linked low levels of C15 to a condition known as cellular fragility syndrome, which affects the stability of cell membranes and could have implications for human health.

Intro

2min

Exploring the Longevity Benefits of C15 Fatty Acid

2min

Understanding Cellular Fragility Syndrome and C15's Role

2min

Understanding C15 and Its Role in Managing Ferritin Levels

2min

Exploring Hyperferritinemia and the Innovative C15 Supplement

3min

Dr. Stephanie Venn-Watson, DVM, MPH is the Co-Founder and CEO of Seraphina Therapeutics, a pioneering health and wellness company dedicated to discovering and developing essential fatty acids that support longevity and overall well-being. A veterinary epidemiologist and the world’s foremost expert on C15:0, the first essential fatty acid discovered in over 90 years, Stephanie has revolutionized the way we think about nutrition and aging.

Her career spans impactful roles, including serving as an epidemiologist for the World Health Organization and U.S. Navy. With over 60 patents and 80 peer-reviewed publications, her innovative approach to nutrient-based therapeutics has been spotlighted by NPR’s Science Friday, CBS, BBC, and National Geographic.

Stephanie’s groundbreaking contributions have earned her prestigious accolades, including the Department of Health and Human Services Secretary’s Award for Innovations in Disease Prevention and Health Promotion and Boehringer Ingelheim’s Innovation Award. Under her leadership, Seraphina Therapeutics has been recognized as a Fast Company World Changing Idea and won Nutritional Outlook Magazine’s Best of the Industry award for its pure C15:0 ingredient.

She holds a B.S. in Animal Physiology and Neuroscience from UC San Diego, a D.V.M. from Tufts University, and an M.P.H. from Emory University. She was also a National Research Council Associate with the Armed Forces Medical Intelligence Center and is an Albert Schweitzer Fellow for Life.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.